| |
Free β-hCG (ng/ml)
| |
PAPP-A (mIU/ml)
| |
---|
Sample
|
Control Module LFBCM
|
Human serum
|
Control Module LPCCM
|
Human serum
|
---|
|
Control 1
|
Control 2
|
Control 3
| |
Control 1
|
Control 2
| |
---|
Target
|
5.1
|
23.8
|
74.2
| |
0.40
|
1.96
| |
2SD Range
|
(4.2-6.4)
|
(19.8-27.8)
|
(63.6-90.8)
| |
(0.32-0.48)
|
(1.70-2.22)
| |
Within-run
| | | | | | | |
Mean
|
4.84
|
24.1
|
72.8
|
66.6
|
0.41
|
1.94
|
2.58
|
SD
|
0.15
|
1.12
|
3.50
|
2.40
|
0.01
|
0.06
|
0.17
|
CV* (%)
|
3.09
|
4.65
|
4.81
|
3.60
|
2.44
|
3.09
|
6.59
|
Between-run
| | | | | | | |
Mean
|
4.75
|
22.66
|
71.66
|
61.7
|
0.38
|
1.94
|
2.39
|
SD
|
0.31
|
1.70
|
5.25
|
4.13
|
0.02
|
0.11
|
0.21
|
CV* (%)
|
6.52
|
7.50
|
7.32
|
6.69
|
5.26
|
5.67
|
8.79
|
- CV* - coefficient of variation